Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. - Wikidata - wikimedia - TriplyDB

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

http://www.wikidata.org/entity/Q36454797

about

Molecular mechanisms underlying antiproliferative and differentiating responses of hepatocarcinoma cells to subthermal electric stimulation “Quo Vadis” Oncologic Hyperthermia?Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives Current state of the art of regional hyperthermia treatment planning: a review Temperature matters! And why it should matter to tumor immunologists Gold nanoparticles as novel agents for cancer therapy Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.Low-intensity continuous ultrasound triggers effective bisphosphonate anticancer activity in breast cancer.Treatment of Adult Soft Tissue Sarcomas: An Overview Can oncology recapitulate paleontology? Lessons from species extinctions Thermal therapy of pancreatic tumours using endoluminal ultrasound: Parametric and patient-specific modelling Ultrasound-activated agents comprised of 5FU-bearing nanoparticles bonded to microbubbles inhibit solid tumor growth and improve survival.Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array.Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.Reduction of peak acoustic pressure and shaping of heated region by use of multifoci sonications in MR-guided high-intensity focused ultrasound mediated mild hyperthermia The ongoing history of thermal therapy for cancer T1 and T2 temperature dependence of female human breast adipose tissue at 1.5 T: groundwork for monitoring thermal therapies in the breast.Rationale of hyperthermia for radio(chemo)therapy and immune responses in patients with bladder cancer: Biological concepts, clinical data, interdisciplinary treatment decisions and biological tumour imaging.Natural biology and management of nonmuscle invasive bladder cancer.Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics.The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines In vivo evaluation of small-molecule thermoresponsive anticancer drugs potentiated by hyperthermia.Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.A heterogeneous human tissue mimicking phantom for RF heating and MRI thermal monitoring verification.Implementation of treatment planning in the routine clinical procedure of regional hyperthermia treatment of cervical cancer: an overview and the Rotterdam experience.Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor?Fever and the thermal regulation of immunity: the immune system feels the heat.Inactivation of DNA-dependent protein kinase promotes heat-induced apoptosis independently of heat-shock protein induction in human cancer cell lines.SEOM clinical guidelines for the management of adult soft tissue sarcomas.Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.[Synovial tumors and tumor-like lesions].Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla.Fever-range hyperthermia vs. hypothermia effect on cancer cell viability, proliferation and HSP90 expression.Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition.Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.

P2860

Q21132368-D1A6CB04-0102-4569-AA6A-4C788490F344 Q21285105-01171101-7AF8-46CA-B32E-5E1FE98D4450 Q26747847-636A7B43-9402-49CA-BF41-610C43BFB39A Q26783500-B8CE0485-0850-4D8C-A4A8-D53062D5DE74 Q26853269-9A4DF3B0-235C-4FCC-8935-7FADD8B003C4 Q27008020-D716CFD9-7116-42D5-8969-7667660C4175 Q27300805-047AA1DF-F3F1-40F2-9D4E-9D187E22A09A Q27306861-D2090AA8-C8D8-44E4-B280-340A398F57E8 Q28088685-D8760C56-D5B2-4734-A20B-5D67AAAA3884 Q28607703-70DFA52E-E268-489F-BBC0-0B1A8A08C737 Q30380596-4D05981A-A8BA-4AAD-A6AA-D7142977BE4A Q30408398-1AE38358-BD87-4EF7-B806-3BBE87F6AEE0 Q30417816-E3CCB846-8D6B-443D-BC1C-52671F22D15F Q30429246-3BED9792-43BE-4B87-AE02-87BEA27C339E Q30445172-BD9BD188-AC1C-4513-9B1C-08894DC0CE52 Q30469171-525EA790-03E7-4860-9688-7080C4DC2778 Q30996846-E7D49BD4-943D-4618-8406-10510F0FB6A0 Q31070048-6FA63F63-D5CE-471B-BD5F-86A6923B8FBA Q33561637-13EB819A-2B33-4433-84CB-A3FF0D7D40E3 Q33656296-63383CB7-E33D-4DD5-8611-6832D80FA0E2 Q33757142-186E15C1-61D5-4D70-BE97-5186D7A0E2E8 Q33811587-443D571F-1119-4746-A23D-5BE377E08662 Q33832073-4F2D4F28-E5E6-4E19-8C25-6FA6F0940E24 Q33847893-3CC169AA-B44A-4A26-872E-8EC1AE2D667D Q33879424-90E72AB1-0425-43E2-9FA9-5BAF878D05B9 Q34094887-F5071D02-2835-46A1-B250-7AA1A89CD848 Q34202172-1F9C0F09-8531-4C61-BD1F-4DE3F7AE4DE5 Q34300911-AC822EFD-56C8-4156-9027-74A7E4E6E3E1 Q34388088-6F05E444-76FD-49EA-B4DF-CC237F03C288 Q34449535-15D4D544-1112-4716-8A5D-42657F58A6DA Q34476418-A2B9C623-998B-4BEA-8C13-B7B4BE312159 Q34625724-E2F37DE9-65A9-4923-B8B3-BA150CC33CFA Q34639506-7A72660F-6AE7-4226-912A-C1499148D481 Q34664479-A9CA70F2-0022-425B-B721-98D41E5DF7F8 Q34673094-AECDDA28-F7DD-4B0C-94BC-8E617A22C053 Q34684765-FED3F21C-4421-4579-B7D2-576DA921757E Q35032248-B985B620-8B54-471F-889E-E20348E53F06 Q35049271-54D488B9-9809-4576-A300-D68354D9516F Q35067230-EA3B71C9-7FBF-4624-BE57-BF4F8AEB1339 Q35369944-B3CB5B01-B04E-4DCE-9976-C12476738535

P2860

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

http://www.wikidata.org/entity/Q36454797

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Neo-adjuvant chemotherapy alon ...... sed phase 3 multicentre study.

@ast

Neo-adjuvant chemotherapy alon ...... sed phase 3 multicentre study.

@en

type

label

Neo-adjuvant chemotherapy alon ...... sed phase 3 multicentre study.

@ast

Neo-adjuvant chemotherapy alon ...... sed phase 3 multicentre study.

@en

prefLabel

Neo-adjuvant chemotherapy alon ...... sed phase 3 multicentre study.

@ast

Neo-adjuvant chemotherapy alon ...... sed phase 3 multicentre study.

@en

P1433

Q36454797-1BA8828F-1621-4BC5-B2FF-57249EE8C85B

P1476

Q36454797-6C53023E-8D27-4D51-AD93-4EB04D8A5168

P2093

Q36454797-0C147B95-0BD4-4203-B0B9-CBB722617E80

Q36454797-0EBB3534-EB04-4EE3-88F8-D98BFC169ADC

Q36454797-10FC483D-F111-45CC-B190-694DCA9E8EB6

Q36454797-18E94700-83B6-4CF6-B990-2AED5DC7B699

Q36454797-28096DED-6607-4D79-8506-DDEBFB01EE8A

Q36454797-3B391053-0A7E-4175-AFA3-99B13E03F87D

Q36454797-4CD20040-8034-4457-9D93-7994F1DED9D3

Q36454797-5D31F797-665E-4595-9C6C-625DF4650CE5

Q36454797-7E5572ED-97FB-4420-8C70-A45C7529F13E

Q36454797-7FF9B9AD-BEB3-474D-9F24-295FF900D656

P2860

Q36454797-0FBFE260-CF75-40D9-BD7A-014B0D095747

Q36454797-2089E783-5238-42CC-960A-B998A185E811

Q36454797-2FA0C850-7F2E-4053-93A0-02E3B8D38403

Q36454797-3234811A-9105-4CEB-B779-DDFF6E2C3EED

Q36454797-4B8FE79F-BCCB-422E-9DB0-968D0E4ED58A

Q36454797-4EE66816-87B7-4E11-891E-9D9A1D7D275D

Q36454797-52F3B6D3-7005-466D-ADAB-7302B2ED4B6C

Q36454797-662D0A71-5AB4-4ED2-BA3F-5B561F216DB8

Q36454797-6D957ED9-3F2A-49AE-9061-9C83FF101312

Q36454797-740EF888-0818-4E70-879E-E1CCE2706DF9

P304

Q36454797-C06CA8A0-FF31-4D08-AE61-CC9418D12422

P31

Q36454797-6A056622-B655-4CB0-921D-0395E495890D

P356

Q36454797-1B3C0CC6-1A04-4B6F-AACF-19E4D5A9065C

P433

Q36454797-12BC756A-F918-4CA6-985A-E71B88F17011

P478

Q36454797-7EDC277A-7880-4D66-9BC6-54F175E6F8D9

P50

Q36454797-35C41D88-6872-4BAB-BD27-E212B6214850

Q36454797-4E5BF64B-628B-4BF5-8DA2-F33CDA7B5B06

Q36454797-C16E39C7-5DF4-4867-9DA9-30A3C37CDDD6

P577

Q36454797-4DD0BE21-43DD-4440-B9A5-DFA18D75A1FF

P5875

Q36454797-D31B7160-B907-4A8B-AAA0-87F1A5CC1FC9

P698

Q36454797-C564F494-24B0-4897-8826-FD7E5447FA1B

P921

Q36454797-4EF282B7-BE1B-432E-A816-74C58ECDD959

Q36454797-9055C5BD-1440-408F-8F4A-51E930A015B4

P932

Q36454797-C1F8BD0C-9194-4952-8F1E-9D163A32E02A

P356

S1470-2045(10)70071-1

P1433

The Lancet Oncology

P1476

Neo-adjuvant chemotherapy alon ...... sed phase 3 multicentre study.

@en

P2093

Andrea Baur-Melnyk

http://www.w3.org/2001/XMLSchema#string

Baard-Christian Schem

http://www.w3.org/2001/XMLSchema#string

Christoph Salat

http://www.w3.org/2001/XMLSchema#string

European Organisation for Rese ...... ne Sarcoma Group (EORTC-STBSG)

http://www.w3.org/2001/XMLSchema#string

European Society for Hyperthermic Oncology (ESHO)

http://www.w3.org/2001/XMLSchema#string

Ferdinand Ploner

http://www.w3.org/2001/XMLSchema#string

Hans Roland Dürr

http://www.w3.org/2001/XMLSchema#string

Jaap Verweij

http://www.w3.org/2001/XMLSchema#string

Karl-Walter Jauch

http://www.w3.org/2001/XMLSchema#string

Peter Hohenberger

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

Cancer statistics, 2004

Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

Hyperthermia in combined treatment of cancer.

Adjuvant chemotherapy for soft tissue sarcoma.

Soft-tissue sarcomas in adults.

Current concepts in multimodality therapy for retroperitoneal sarcoma.

Evidence-based recommendations for local therapy for soft tissue sarcomas.

Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature.

P304

561-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1470-2045(10)70071-1

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Clemens-Martin Wendtner

P577

2010-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43533433

http://www.w3.org/2001/XMLSchema#string

P698

20434400

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

3517819

http://www.w3.org/2001/XMLSchema#string